Cancer Moonshot℠ Blue Ribbon Panel Members
The Blue Ribbon Panel is composed of leading experts from a broad range of scientific areas, including biology, immunology, genomics, diagnostics, bioinformatics, and cancer prevention and treatment. Members also include investigators with expertise in clinical trials and cancer health disparities, as well as representatives of cancer advocacy groups and pharmaceutical and biotechnology companies.
The members of the Blue Ribbon Panel are:
Tyler Jacks, Ph.D. (Co-Chair)
Chair, National Cancer Advisory Board
Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Elizabeth Jaffee, M.D. (Co-Chair)
Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Dinah Singer, Ph.D. (Co-Chair and Designated Federal Official)
Acting Deputy Director, National Cancer Institute
Director, Division of Cancer Biology, National Cancer Institute
Peter Adamson, M.D.
Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia
James Allison, Ph.D.
Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center
David Arons, J.D.
Chief Executive Officer, National Brain Tumor Society
Mary Beckerle, Ph.D.
Chief Executive Officer and Director, Huntsman Cancer Institute, University of Utah
Mitch Berger, M.D.
Professor and Chair, Department of Neurological Surgery, University of California, San Francisco
Jeff Bluestone, Ph.D.
A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology, University of California, San Francisco
Chi Van Dang, M.D., Ph.D.
Scientific Director, Ludwig Cancer Research
Mikael Dolsten, M.D., Ph.D.
President, Pfizer Worldwide Research and Development
Executive Vice President, Pfizer, Inc.
James Downing, M.D.
President and Chief Executive Officer, St. Jude Children’s Research Hospital
Levi Garraway, M.D., Ph.D.
Senior Vice President, Global Development and Medical Affairs, Lilly Oncology, Eli Lilly and Company
Gad Getz, Ph.D.
Director of Cancer Genome Computational Analysis Group and Institute Member, Broad Institute of MIT and Harvard
Director, Bioinformatics Program, Massachusetts General Hospital Cancer Center and Department of Pathology
Associate Professor of Pathology, Harvard Medical School
Paul C. Zamecnik Chair in Oncology, MGH Cancer Center
Laurie Glimcher, M.D.
Professor of Medicine and Stephen and Suzanne Weiss Dean, Weill Cornell Medical College
Incoming President and Chief Executive Officer, Dana-Farber Cancer Institute
Lifang Hou, M.D., Ph.D.
Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Neal Kassell, M.D.
Chairman, Focused Ultrasound Foundation
Professor of Neurosurgery, University of Virginia
María Elena Martínez, Ph.D.
Sam M. Walton Endowed Chair for Cancer Research, Professor of Family Medicine and Public Health, and Co-director of the Reducing Cancer Disparities Program, UC San Diego Moores Cancer Center
Deborah Mayer, Ph.D., R.N.
Professor of Adult and Geriatric Health, University of North Carolina School of Nursing
Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center
Edith Mitchell, M.D., F.A.C.P
Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University
Augusto Ochoa, M.D.
Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University
Jennifer Pietenpol, Ph.D.
Benjamin F. Byrd, Jr. Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center
Angel Pizarro, M.S.E.
Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing
Barbara Rimer, Dr.P.H.
Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health
Charles Sawyers, M.D.
Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Investigator, Howard Hughes Medical Institute
Ellen Sigal, Ph.D.
Founder and Chair, Friends of Cancer Research
Patrick Soon-Shiong, M.D., FRCS (C), FACS
Founder, Chair, and CEO, NantWorks LLC
Wai-Kwan Alfred Yung, M.D.
Professor of Neuro-Oncology and Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center
Ex Officio members of the Blue Ribbon Panel are:
David Atkins, M.D., M.P.H.
Acting Chief Research and Development Officer, Department of Veterans Affairs
Robert Califf, M.D.
Commissioner, U.S. Food and Drug Administration
Karen Guice, M.D., M.P.P.
Acting Assistant Secretary of Defense for Health Affairs, Department of Defense
Jason Paragas, Ph.D.
Director of Innovation, Lawrence Livermore National Laboratory
Lawrence Tabak, D.D.S., Ph.D.
Principal Deputy Director, National Institutes of Health